In addition, it might be speculated that elevated levels of sFRP5 might be an indication for a better clinical outcome of COVID-19 in obese as well as T2D patients, which could be interesting to examine in future biomarker studies. The gene discussed is SFRP5; the disease is type 2 diabetes mellitus.